DEUTSCHE BANK AG\ - ARATANA THERAPEUTICS INC ownership

ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 46 filers reported holding ARATANA THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ARATANA THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$178,000
-78.5%
34,964
-84.8%
0.00%
Q1 2019$829,000
-23.2%
230,516
+30.8%
0.00%
-100.0%
Q4 2018$1,079,000
-40.3%
176,187
-43.1%
0.00%0.0%
Q3 2018$1,808,000
-4.2%
309,823
-30.3%
0.00%0.0%
Q2 2018$1,887,000
+8.8%
444,360
+12.9%
0.00%0.0%
Q1 2018$1,734,000
-29.5%
393,546
-15.9%
0.00%
-50.0%
Q4 2017$2,461,000
-4.6%
468,114
+11.2%
0.00%0.0%
Q3 2017$2,579,000
-4.3%
420,936
+12.8%
0.00%0.0%
Q2 2017$2,696,000
+107.5%
373,043
+52.0%
0.00%
+100.0%
Q1 2017$1,299,000
-27.9%
245,399
-2.2%
0.00%0.0%
Q4 2016$1,801,000
-26.5%
250,959
-4.2%
0.00%
-50.0%
Q3 2016$2,451,000
+30.2%
261,926
-12.1%
0.00%
+100.0%
Q2 2016$1,883,000
+49.8%
298,106
+30.8%
0.00%0.0%
Q1 2016$1,257,000
-21.1%
227,857
-20.3%
0.00%0.0%
Q4 2015$1,594,000
-15.5%
285,997
+28.2%
0.00%0.0%
Q3 2015$1,886,000
-33.1%
223,099
+19.5%
0.00%
-50.0%
Q2 2015$2,820,000
+687.7%
186,639
+731.3%
0.00%
Q1 2015$358,000
-54.7%
22,451
-49.5%
0.00%
Q4 2014$790,000
+60.6%
44,436
-9.6%
0.00%
Q3 2014$492,000
+28.1%
49,157
+98.6%
0.00%
Q2 2014$384,000
-41.6%
24,749
-30.3%
0.00%
Q1 2014$657,000
+303.1%
35,490
+311.7%
0.00%
Q4 2013$163,000
-29.4%
8,620
-39.2%
0.00%
Q3 2013$231,00014,1680.00%
Other shareholders
ARATANA THERAPEUTICS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Engaged Capital LLC 3,487,149$21,376,0003.96%
Broadfin Capital, LLC 4,083,135$25,030,0003.29%
MPM ASSET MANAGEMENT LLC 250,000$1,533,0001.30%
GENERAL AMERICAN INVESTORS CO INC 1,599,365$9,804,0001.03%
Grandeur Peak Global Advisors, LLC 821,038$5,033,0000.65%
CADENCE CAPITAL MANAGEMENT LLC 307,294$1,884,0000.19%
Redmond Asset Management, LLC 60,176$369,0000.18%
Alambic Investment Management, L.P. 65,000$398,0000.17%
MENTA CAPITAL LLC 39,562$243,0000.09%
Campbell & CO Investment Adviser LLC 12,990$88,0000.09%
View complete list of ARATANA THERAPEUTICS INC shareholders